AI assistant
IRADIMED CORP — Director's Dealing 2023
Dec 15, 2023
32324_dirs_2023-12-14_323cdd87-b3fe-4f45-891d-1b15f7306a7c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2023-12-12
Reporting Person: HAWKINS JAMES B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-12 | Common Stock | A | 468 | $7.10 | Acquired | 39816 | Direct |
| 2023-12-12 | Common Stock | S | 468 | $43.395 | Disposed | 39348 | Direct |
| 2023-12-12 | Common Stock | A | 504 | $9.84 | Acquired | 39852 | Direct |
| 2023-12-12 | Common Stock | S | 504 | $43.395 | Disposed | 39348 | Direct |
| 2023-12-13 | Common Stock | A | 5000 | $9.84 | Acquired | 44348 | Direct |
| 2023-12-13 | Common Stock | S | 5000 | $42.7977 | Disposed | 39348 | Direct |
| 2023-12-13 | Common Stock | A | 219 | $9.84 | Acquired | 39567 | Direct |
| 2023-12-13 | Common Stock | S | 219 | $43.6137 | Disposed | 39348 | Direct |
| 2023-12-14 | Common Stock | A | 4277 | $9.84 | Acquired | 43625 | Direct |
| 2023-12-14 | Common Stock | S | 4277 | $44.5843 | Disposed | 39348 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-12 | Stock Options (Right to Buy) | $7.10 | M | 468 | Disposed | 2024-09-29 | Common Stock (468) | Direct |
| 2023-12-12 | Stock Options (Right to Buy) | $9.84 | M | 504 | Disposed | 2024-12-15 | Common Stock (504) | Direct |
| 2023-12-13 | Stock Options (right to buy) | $9.84 | M | 5000 | Disposed | 2024-12-15 | Common Stock (5000) | Direct |
| 2023-12-13 | Stock Options 9right to buy) | $9.84 | M | 219 | Disposed | 2024-12-15 | Common Stock (219) | Direct |
| 2023-12-14 | Stock Options (right to buy) | $9.84 | M | 4277 | Disposed | 2024-12-15 | Common Stock (4277) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 10,000 shares, was granted on 9-29-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2: This transaction was executed in multiple trades at prices ranging from $43.25 to $43.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This option, representing a right to purchase a total of 10,000 shares, was granted on 12-15-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F4: This transaction was executed in multiple trades at prices ranging from $42.25 to $43.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $44.50 to $44.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.